Delivery Order SPE2DB22D1017-SPE2DB25FG2PC
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,520.76 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,502,370 units of the Typhim VI 25 mcg/0.5 mL syringe vaccine. The contract, which does not have a set-aside designation, has an ultimate completion date of August 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,028,982 units of the Typhim VI 25 mcg/0.5 mL syringe vaccine. The contract has a ceiling value of $1,368.40 and a period of performance through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,617.86 contract is for the provision of 4,563,955,495 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,829,247 Typhim VI 25 MCG/0.5 ML Vial 10ML vaccines. The $6,156.31 firm fixed price contract has a period of performance through September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support Medical and other federal agencies to provide a wide range...
This is a $39,598.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for the supply of 4,565,235,791 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a period of performance through July 25, 2024 and was awarded on July 24, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,439.57, is a delivery order for the supply of 4,563,296,422 units of the Typhim VI 25 mcg/0.5 mL syringe 0.5 mL vaccine. The contract has a firm fixed price pricing type and an ultimate completion date of January 11, 2024. It is not designated with a set-aside requirement, indicating open...
The U.S. Defense Logistics Agency (DLA) awarded a $7,451.67 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,956,103 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the procurement of 4,558,073,815 doses of the Typhim VI 25 mcg/0.5 ml vaccine syringe. The $3,448.15 firm-fixed price contract has an ultimate completion date of August 12, 2022. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, primarily serving the Department of Defense...
This federal contract award, valued at $12,818.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,073,471 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a performance period extending through April 30, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The $3,421.00 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 indefinite delivery contract with DLA as the primary vehicle for delivering pharmaceutical...